DOMS Industries Limited — PPTs, 03-02-2025: Investor Presentation

**1. Financial Highlights:** DOMS Industries reported a significant increase in consolidated operating revenues, reaching ₹1,403.9 Cr for the nine months ending December 31, 2024, up 23.9% YoY. EBITDA improved by 32.2% to ₹260.2 Cr, while PAT surged by 43.9% to ₹162.3 Cr. Gross profit for the period rose to ₹608.6 Cr, reflecting a 30.4% increase from the previous year.

**2. Strategic Initiatives and Growth Drivers:** The company emphasizes a diversified product portfolio and continues investing in scalable, integrated manufacturing infrastructure. DOMS is expanding its operational footprint, with ongoing construction of a new facility spanning over 44 acres.

**3. Business Developments:** Recent strategic moves include the acquisition of a majority stake in Uniclan Healthcare, enhancing its product offerings in baby hygiene.

**4. Market Position and Competitive Advantage:** DOMS maintains a strong market presence with over 28 states covered and exports to multiple countries. The partnership with F.I.L.A. provides access to global markets, enhancing product expertise.

**5. Investor Implications:** With robust financial growth and strategic expansions, investors may view DOMS as a strong contender for continued growth in the stationery and hygiene product markets. Watch closely for further developments regarding the new facility and potential product introductions.